Search Results - "El Hajra, I"

Ampullary neuroendocrine tumor: A rare cause of abdominal pain by El Hajra, I., Agudo, B., González-Haba, M.

Get full text

DOP04 Inflammatory Bowel Disease (IBD) and Solid Organ Transplantation. Natural history of pre-existing and de novo IBD patients. (EITOS study of GETECCU) by Bastón Rey, I, Calvino Suárez, C, Luque, A M, Caballol, B, Soutullo, C, Bravo, A, Castaño, A, Gros, B, Bernal, L, Diz Lois, M T, Alonso Galán, H, Cañete, F, Castro, B, Pérez Galindo, P, González Muñoza, C, El Hajra, I, Martínez Montiel, P, Alonso Abreu, I, Mesonero, F, González Vivo, M, Peries, L, Martín Arranz, E, Abril, C, Marín Jiménez, I, Baltar, R, Vicuna, M, Moreno, N, Brunet, E, Rubín de Célix, C, Fajardo, I, Cruz, N, Rojas Feria, M, Fernández Clotet, A, Gimeno, M, Zabana, Y, Suárez Ferrer, C, Rodríguez Lago, I, Barreiro de Acosta, M

“…Abstract Background Limited data is available of the outcome of inflammatory bowel disease (IBD) in patients with solid organ transplantation (SOT). The aim of…”
Get full text

P349 Safety of Inflammatory Bowel Disease treatments in patients with Solid Organ Transplantation (EITOS study of GETECCU) by Bastón Rey, I, Calvino Suárez, C, Luque, A M, Caballol, B, Soutullo, C, Bravo, A, Castaño, A, Gros, B, Hurtado, A, Vázquez Rey, T, Alonso Galán, H, Cañete, F, Castro, B, Pérez Galindo, P, González Muñoza, C, El Hajra, I, Martínez Montiel, P, Alonso Abreu, I, Mesonero, F, González Vivo, M, Peries, L, Martín Arranz, E, Abril, C, Marín Jiménez, I, Baltar, R, Vicuña, M, Moreno, N, Brunet, E, Rodríguez Lago, I, Rubín de Célix, C, Fajardo, I, Cruz, N, Rojas Feria, M, Fernández Clotet, A, Gimeno, M, Zabana, Y, Suárez Ferrer, C, Barreiro de Acosta, M

“…Abstract Background Inflammatory bowel disease (IBD) in patients with solid organ transplantation (SOT) is associated with a greater complexity in their…”
Get full text

P319 Impact of biological agents on postoperative complications in inflammatory bowel disease: a multicentre study of GETECCU by García García, M J, Rivero, M, Miranda-Bautista, J, Bastón-Rey, I, Mesonero, F, Leo-Carnerero, E, Casas-Deza, D, Cagigas Fernández, C, Martin-Cardona, A, El Hajra, I, Hernández-Aretxabaleta, N, Pérez-Martínez, I, Fuentes-Valenzuela, E, Jiménez, N, Rubín de Célix, C, Gutiérrez, A, Suárez Ferrer, C, Huguet, J M, Fernández-Clotet, A, González-Vivó, M, Del Val, B, Castro-Poceiro, J, Melcarne, L, Dueñas, C, Izquierdo, M, Monfort, D, Bouhmidi, A, Ramírez De la Piscina, P, Romero, E, Molina, G, Zorrilla, J, Calvino-Suárez, C, Sánchez, E, Nuñez, A, Sierra, O, Castro, B, Zabana, Y, González-Partida, I, Chaparro, M, Gisbert, J P

“…Abstract Background It has been suggested that biologic therapy may increase the risk of postoperative complications in inflammatory bowel disease (IBD), but…”
Get full text

P533 Adalimumab 80mg every other week in inflammatory bowel disease: Treatment intensification outcomes in real life clinical practice by Calvo Moya, M I, Omella Usieto, I, El Hajra Martinez, I, Santos Perez, E, Gonzalez Lama, Y, Ruiz Antoran, B, Menchen Viso, B, Matallana Royo, V, Gonzalez Partida, I, De Lucas Tellez de Meneses, R, Bella del Castillo, P, Gonzalez Rodriguez, M, Vera Mendoza, M I

“…Abstract Background Adalimumab (ADA) intensification is recommended for inadequate or loss of response in inflammatory bowel disease (IBD) patients. A new…”
Get full text